🇺🇸 FDA
Pipeline program

Xanthohumol

Placeholder

Phase 2 small_molecule active

Quick answer

Xanthohumol for Crohn Disease is a Phase 2 program (small_molecule) at NORTHWEST BIOTHERAPEUTICS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
NORTHWEST BIOTHERAPEUTICS INC
Indication
Crohn Disease
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials